Literature DB >> 29344634

Underlying mechanism of the photodynamic activity of hematoporphyrin‑induced apoptosis in U87 glioma cells.

Shi-Xiang Yuan1, Jun-Liang Li2, Xin-Ke Xu2, Wei Chen2, Cheng Chen2, Kun-Qi Kuang3, Fang-Yu Wang2, Kai Wang4, Fang-Cheng Li2.   

Abstract

Photodynamic therapy (PDT) is a relatively novel type of tumor therapy method with low toxicity and limited side‑effects. The aim of the present study was to investigate the underlying mechanism and potential microRNAs (miRNAs) involved in the treatment of glioma by PDT with hematoporphyrin, a clinical photosensitizer. The photodynamic activity of hematoporphyrin on the cell viability and apoptosis of gliomas was investigated by MTT, and flow cytometry and fluorescence microscopy, respectively. Alterations in singlet oxygen and mitochondrial membrane potential were detected. The differentially expressed miRNAs and proteins were evaluated by miRNA gene chip and apoptosis‑associated protein chip, respectively. The results demonstrated that cell viability significantly decreased with hematoporphyrin concentration. PDT with hematoporphyrin significantly increased cell apoptosis at a later stage, induced the content of reactive oxygen species (ROS) and decreased the mitochondrial membrane potential, indicating that PDT with hematoporphyrin inhibited cell growth via induction of radical oxygen, decreased the mitochondrial membrane potential and induced apoptosis. The upregulated miRNAs, including hsa‑miR‑7641, hsa‑miR‑9500, hsa‑miR‑4459, hsa‑miR‑21‑5p, hsa‑miR‑663a and hsa‑miR‑205‑5p may be important in PDT‑induced cell apoptosis in glioma. Transporter 1, ATP binding cassette subfamily B member‑ and nuclear factor‑κB‑mediated apoptosis signaling pathways were the most significant pathways. Thus, the current study presents PDT as a potential therapeutic approach for the treatment of malignant glioma, and identified miRNAs for the molecular design and development of a third‑generation photosensitizer (PS).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29344634     DOI: 10.3892/ijmm.2018.3400

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice.

Authors:  Daozhou Liu; Qifeng Ji; Ying Cheng; Miao Liu; Bangle Zhang; Qibing Mei; Menglei Huan; Siyuan Zhou
Journal:  J Nanobiotechnology       Date:  2022-06-03       Impact factor: 9.429

2.  Circ_RPPH1 regulates glioma cell malignancy by binding to miR-627-5p/miR-663a to induce SDC1 expression.

Authors:  Wei Chen; Xiao Yu; Ning Wang; Jiangpeng Jing; Ruichun Li; Minxue Lian
Journal:  Metab Brain Dis       Date:  2022-03-25       Impact factor: 3.584

3.  Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway.

Authors:  Lei Wang; Bojuan Lang; Youdong Zhou; Jinyang Ma; Keqi Hu
Journal:  Cell Cycle       Date:  2021-08-23       Impact factor: 5.173

Review 4.  Using Light for Therapy of Glioblastoma Multiforme (GBM).

Authors:  Alex Vasilev; Roba Sofi; Ruman Rahman; Stuart J Smith; Anja G Teschemacher; Sergey Kasparov
Journal:  Brain Sci       Date:  2020-01-31

5.  Silencing LINC00294 Restores Mitochondrial Function and Inhibits Apoptosis of Glioma Cells under Hypoxia via the miR-21-5p/CASKIN1/cAMP Axis.

Authors:  Xiaogang Dong; Qin Pi; Anwaier Yuemaierabola; Wenjia Guo; Hailong Tian
Journal:  Oxid Med Cell Longev       Date:  2021-11-03       Impact factor: 6.543

6.  Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress.

Authors:  Xuan Wang; Yuting Ji; Dekui Jin; Jingyi Qi; Xuening Hou; Wenting Zhao; Shuaishuai Zhou; Chengying Zhang; Yongting Luo; Peng An; Junjie Luo
Journal:  Nutrients       Date:  2022-02-21       Impact factor: 5.717

7.  Elevated cellular PpIX potentiates sonodynamic therapy in a mouse glioma stem cell-bearing glioma model by downregulating the Akt/NF-κB/MDR1 pathway.

Authors:  Kenji Shono; Yoshifumi Mizobuchi; Izumi Yamaguchi; Kohei Nakajima; Yuri Fujiwara; Toshitaka Fujihara; Keiko Kitazato; Kazuhito Matsuzaki; Yoshihiro Uto; Oltea Sampetrean; Hideyuki Saya; Yasushi Takagi
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.